Parcopa: a rapidly dissolving formulation of carbidopa/levodopa
- PMID: 15706700
Item in Clipboard
Parcopa: a rapidly dissolving formulation of carbidopa/levodopa
Med Lett Drugs Ther.
.
Abstract
Parcopa is an immediate-release formulation of carbidopa/levodopa that dissolves in the tongue. It can be taken without water, which may be an advantage for some patients, but no published information is available.
Similar articles
-
What to do when Sinemet fails: Part one.Clin Neuropharmacol. 1984;7(2):121-33. Clin Neuropharmacol. 1984. PMID: 6733692 No abstract available.
-
Medical treatment of Parkinson's disease.Compr Ther. 1989 Mar;15(3):53-9. Compr Ther. 1989. PMID: 2650977 Review. No abstract available.
-
New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings.Neurology. 1989 Nov;39(11 Suppl 2):1-106. Neurology. 1989. PMID: 2586761 No abstract available.
-
Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.Adv Neurol. 1996;69:487-91. Adv Neurol. 1996. PMID: 8615169 Clinical Trial. No abstract available.
-
IPX066: a novel carbidopa-levodopa extended-release formulation.Expert Rev Neurother. 2012 Feb;12(2):133-40. doi: 10.1586/ern.11.195. Expert Rev Neurother. 2012. PMID: 22288668 Review.
Cited by
-
Initial treatment of Parkinson's disease.Curr Treat Options Neurol. 2006 May;8(3):224-35. doi: 10.1007/s11940-006-0013-y. Curr Treat Options Neurol. 2006. PMID: 16569381
-
Parkinson's disease and motor fluctuations.Curr Treat Options Neurol. 2010 May;12(3):186-99. doi: 10.1007/s11940-010-0067-8. Curr Treat Options Neurol. 2010. PMID: 20842581
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
